Literature DB >> 14675191

Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease?

Christine Bangert1, Josef Friedl, Georg Stary, Georg Stingl, Tamara Kopp.   

Abstract

Contrary to our abundant knowledge about the sensitization phase of human contact hypersensitivity, little is known about the cell types orchestrating the effector phase. In order to address this issue, we phenotypically analyzed biopsies from 72 h epicutaneous patch test reactions (n=10) and normal human skin (n=5) for the presence of various leukocyte differentiation antigens. The inflammatory infiltrate was dominated by CD3+/CD4+ T cells with approximately 30% of the cells coexpressing CD25 and CTLA-4, a phenotype consistent with either activated effector or regulatory T cells. In our search for professional antigen-presenting cells, we were surprised to find not only sizeable numbers of CD1a+ dendritic cells and CD1c+ dendritic cells, but also of CD123+, CD45RA+, BDCA-2+, CLA+, and CD62L+ plasmacytoid dendritic cells. Although virtually absent in normal human skin, these cells were detectable already 6 h after hapten challenge and were often found in close proximity to CD56+ natural killer cells, indicative of a functional interaction between these cell types. The detailed knowledge of the cellular composition of the inflammatory infiltrate in allergic contact dermatitis and its kinetics should form the basis for the investigation of the immunologic and molecular events operative in the perpetuation and resolution of the eczematous response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675191     DOI: 10.1111/j.1523-1747.2003.12623.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  22 in total

Review 1.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin.

Authors:  Carmelo Luci; Ana Reynders; Ivaylo I Ivanov; Celine Cognet; Laurent Chiche; Lionel Chasson; Jean Hardwigsen; Esperanza Anguiano; Jacques Banchereau; Damien Chaussabel; Marc Dalod; Dan R Littman; Eric Vivier; Elena Tomasello
Journal:  Nat Immunol       Date:  2008-11-23       Impact factor: 25.606

Review 3.  A STATus report on DC development.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  J Leukoc Biol       Date:  2012-05-01       Impact factor: 4.962

4.  Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Authors:  Juan C Salazar; Constance D Pope; Meagan W Moore; Jonathan Pope; Thomas G Kiely; Justin D Radolf
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

Review 5.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

6.  Clinical improvement in psoriasis with specific targeting of interleukin-23.

Authors:  Tamara Kopp; Elisabeth Riedl; Christine Bangert; Edward P Bowman; Elli Greisenegger; Ann Horowitz; Harald Kittler; Wendy M Blumenschein; Terrill K McClanahan; Thomas Marbury; Claus Zachariae; Danlin Xu; Xiaoli Shirley Hou; Anish Mehta; Anthe S Zandvliet; Diana Montgomery; Frank van Aarle; Sauzanne Khalilieh
Journal:  Nature       Date:  2015-03-09       Impact factor: 49.962

7.  Innate immune responses to herpes simplex virus type 2 influence skin homing molecule expression by memory CD4+ lymphocytes.

Authors:  David M Koelle; Jay Huang; Michael T Hensel; Christopher L McClurkan
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

Authors:  Hans Skvara; Markus Dawid; Elise Kleyn; Barbara Wolff; Josef G Meingassner; Hilary Knight; Thomas Dumortier; Tamara Kopp; Nasanin Fallahi; Georg Stary; Christoph Burkhart; Olivier Grenet; Juergen Wagner; Youssef Hijazi; Randall E Morris; Claire McGeown; Christiane Rordorf; Christopher E M Griffiths; Georg Stingl; Thomas Jung
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

9.  Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment.

Authors:  Cristina Albanesi; Claudia Scarponi; Sabatino Pallotta; Roberta Daniele; Daniela Bosisio; Stefania Madonna; Paola Fortugno; Safiyè Gonzalvo-Feo; Jean-Denis Franssen; Marc Parmentier; Ornella De Pità; Giampiero Girolomoni; Silvano Sozzani
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307

Review 10.  Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.

Authors:  Jorge Schettini; Pinku Mukherjee
Journal:  Clin Dev Immunol       Date:  2009-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.